Color Genomics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Color Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10997
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color analyzes the genes and helps consumers to understand genetic risk for hereditary high cholesterol, common hereditary cancer, and inherited heart conditions. Its Hereditary Cancer Test analyzes genes for mutations that could increase patient’s risk for breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers. Color is headquartered in Burlingame, California, the US.

Color Genomics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Color Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Color Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Color Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Color Genomics Raises USD52 Million in Venture Financing 11
Color Genomics Raises USD45 Million in Series B Venture Financing 12
Color Genomics Raises USD15 Million in Series A Financing 13
Partnerships 14
Color Genomics Partners with University of California Health 14
Color Genomics Inc – Key Competitors 15
Color Genomics Inc – Key Employees 16
Color Genomics Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Color Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Color Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Color Genomics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Color Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Color Genomics Raises USD52 Million in Venture Financing 11
Color Genomics Raises USD45 Million in Series B Venture Financing 12
Color Genomics Raises USD15 Million in Series A Financing 13
Color Genomics Partners with University of California Health 14
Color Genomics Inc, Key Competitors 15
Color Genomics Inc, Key Employees 16

List of Figures
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Color Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Color Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Color Genomics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Santos Limited:企業の戦略・SWOT・財務分析
    Santos Limited - Strategy, SWOT and Corporate Finance Report Summary Santos Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • NFP Corp.:企業のM&A・事業提携・投資動向
    NFP Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NFP Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Bank of Chongqing Co Ltd:企業の戦略・SWOT・財務分析
    Bank of Chongqing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Chongqing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務分析
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Elavon Inc:企業の戦略・SWOT・財務分析
    Elavon Inc - Strategy, SWOT and Corporate Finance Report Summary Elavon Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nanovis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company offers products such as implant nanosurfaces, implantable scaffolds and cervical plate, lumbar PEEK interbody systems, pedicle screws, injectable bi …
  • Valero Energy Corporation:企業の戦略・SWOT・財務分析
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • FirstEnergy Corp (FE):電力:M&Aディール及び事業提携情報
    Summary FirstEnergy Corp. (FirstEnergy) is a diversified energy company, which generates, transmits, distributes and sells electricity. The company’s regulated distribution companies form one of the nation's largest investor-owned electric systems. Its major electricity generating assets include coa …
  • Kurganmashzavod JSC:企業の戦略的SWOT分析
    Kurganmashzavod JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Delong Holdings Limited:企業の戦略・SWOT・財務情報
    Delong Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Delong Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Computershare Limited (CPU):企業の財務・戦略的SWOT分析
    Computershare Limited (CPU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Guardant Health Inc (GH):企業の製品パイプライン分析2018
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Mashreqbank psc:企業の戦略・SWOT・財務情報
    Mashreqbank psc - Strategy, SWOT and Corporate Finance Report Summary Mashreqbank psc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Prana Biotechnology Ltd (Prana Biotech) is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease and brain cancer, and other major age-related degenerative disorders. It is developing first-in-class therapies for the treatment of ne …
  • Recruit Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Recruit Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Recruit Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cardiva Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • Hanwha Solutions Corp (009830):企業の財務・戦略的SWOT分析
    Summary Hanwha Solutions Corp (Hanwha Solutions), a subsidiary of Hanwha Corp, is a provider of chemicals, solar energy solutions and advanced industrial materials. The company is engaged in the production of inorganic chemical, plastic and polymer products which include chlorine and caustic soda, p …
  • Distil plc:企業の戦略・SWOT・財務情報
    Distil plc - Strategy, SWOT and Corporate Finance Report Summary Distil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bayer CropScience AG:企業のM&A・事業提携・投資動向
    Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆